Plasma microRNA-100 is associated with coronary plaque vulnerability.
Soeki T, Yamaguchi K, Niki T, Uematsu E, Bando S, Matsuura T, Ise T, Kusunose K, Hotchi J, Tobiume T, Yagi S, Fukuda D, Taketani Y, Iwase T, Yamada H, Wakatsuki T, Shimabukuro M, Sata M.
Soeki T, et al. Among authors: yamaguchi k.
Circ J. 2015;79(2):413-8. doi: 10.1253/circj.CJ-14-0958. Epub 2014 Dec 17.
Circ J. 2015.
PMID: 25519160
Free article.
Clinical Trial.